Real-time enrollment status for this copd clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 11:18 PM UTC
| NCT Number | NCT05270525 |
| Recruiting Status | Recruiting |
| Condition | COPD |
| Phase | PHASE2 |
| Target Enrollment | 56 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Verona Pharma plc |
| Last Updated on CT.gov | May 13, 2026 (May 13, 2026) |
As of July 19, 2026: Clinical trial NCT05270525 is currently recruiting participants. This phase2 study for copd is actively seeking new participants at 3 locations across the United States. The study is sponsored by Verona Pharma plc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05270525 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05270525 was last updated May 13, 2026 (May 13, 2026). HelloStudys verifies this status automatically.